Bacterial infections Bedaquiline IND Ceftobiprole Ceftolozane / tazobactam IND Citric acid / lactic acid / potassium bitartrate IND Clindamycin Delafloxacin IND Delamanid Deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adults, adolescents and children with a body weight of at least 30kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. IND Deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adults, adolescents, and children and infants with a body weight of at least 10kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. IND Eravacycline Imipenem / cilastatin / relebactam Recarbrio is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options. Treatment of hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP), in adults. Treatment of bacteraemia that occurs in association with, or is suspected to be associated with HAP or VAP, in adults. IND Ozenoxacine SER 109 Tebipenem COVID-19 APN01 Anakinra IND Bamlanivimab/ etesevimab Baricitinib IND Casirivimab/imdevimab Dapagliflozine IND Molnupiravir PF-07321332 / ritonavir Regdanvimab IND Remdesivir IND Sotrovimab Tocilizumab IND Fungal infections Ibrexafungerp IND Oteseconazole Posaconazol Extension of indication to include primary treatment of invasive aspergillosis in adults and adolescents from 13 years of age for Noxafil gastroresistant tablet and concentrate for solution for infusion. IND Extension of indication to include primary treatment of invasive aspergillosis in paediatric patients from 2 years of age weighing more than 40kg and adults for Noxafil gastroresistant tablet and concentrate for solution for infusion. Noxafil gastro-resistant tablets and solution are indicated for use in the treatment of the following fungal infections: Invasive aspergillosis in patients with disease that is refractory to amphotericin B or itraconazole or in patients who are intolerant of these medicinal products. IND Rezafungin HIV Atazanavir / cobicistat Cabotegravir Fostemsavir Lenacapavir Infectious diseases other Fluticasone propionate Tixagevimab / cilgavimab Viral infections other Baloxavir marboxil Bizalimogene ralaplasmid Bulevirtide Doravirine / lamivudine / tenofovirdisoproxil IND Elbasvir / grazoprevir IND Glecaprevir / pibrentasvir IND Lonafarnib IND Maribavir Nirsevimab Sofosbuvir / velpatasvir / voxilaprevi IND Tecovirimat sofosbuvir / velpatasvir IND